In This Section
Our own Dustin McDonald joined Mindbuzz and Tetragram to participate in a discussion on how journaling can help medical cannabis patients achieve better treatment results. This conversation between Dustin, Walt Rampata, Charles Smith, Connor Sheffield, Dr. Janice Knox and Otha Smith III was hosted on July 10, 2020.
Watch David Mangone, the principal author of ASA's 2019 State of the States Report as he explains how our grades and scoring work, what's new in the 2019 edition, how to use the report for advocacy and takes some time to answer viewer questions. This webinar was hosted on August 13th, 2019 and the video has been very lightly edited to remove a few technical errors. For more information, or to download a copy of the report please visit: www.safeaccessnow.org/sos
Rep Bryan Terry, Chairman of the Tennessee House Health Committee, speaking at ASA's pre-conference event during the National Conference of State Legislatures Legislative Summit. The event, which was co-hosted by ASA and WM Policy, welcomed over 150 legislators to celebrate the release of ASA's "2019 State of the States Report: An Analysis of Medical Cannabis Access in the United States." You can download the report for free here: https://www.safeaccessnow.org/sos
At this year's Collision Conference in Toronto, Canada, Sherer was on a panel discussing lessons to be learned from Canada’s experience. Also on the panel were Hilary Black, Chief Advocacy Officer for Canopy Growth Corporation and Sara Brittany Somerset, a cannabis reporter for Forbes. The panel considered what innovations coming out of Canada mean for the industry, for healthcare and for the patient-consumer.
Earlier this spring, the Food and Drug Administration (FDA) issued a notice in the Federal Register that invited the public to submit scientific information and comments on cannabis and cannabis products. We want to ensure that you know how to submit comments that will be convincing regulators and how to avoid common pitfalls we see in many comments. This webinar will help walk you through the comment submission process and give you advice on how to formulate a comment that will help convince the FDA.
This two part webinar series discusses the Cascade of Care Model for Medical Cannabis.
Our own David Mangone joined CannaTalk with Roz and Minorities 4 Medical Marijuana to participate in a discussion of equity in the medical cannabis industry. This conversation between David, Roz McCarthy, Erik Range, and Scheril Murray Powell was hosted on Facebook Live on May 17, 2019.
Michelle Newhart, PhD and William Dolphin discuss their new book, The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience. Learn what their research on mid-life patients in Colorado reveals about what it means to participate in a state medical cannabis program. Hear how patient experiences with medical cannabis fit with that of other medicines -- and don’t -- and hear how that's changing as medicalization marches forward alongside competing "recreational" definitions that complicate the issue.
American is experiencing an Opioid Crisis and looking for solutions. Could medical cannabis help? Dr. Ethan Russo and Americans for Safe Access (ASA) held this live webinar on September 6th, 2017 with the participation of ASA members across the country.
Intellectual property assets (patents, trademarks, copyrights, etc.) form the foundation of most companies' business plans, and can represent up to 80% of a company's valuation. But businesses in the cannabis industry face special challenges because most intellectual property assets are based in federal law. Find out more about those challenges, and what other types of protections are available instead, at this overview of intellectual property strategies especially for cannabis company founders, inventors and investors.
There needs to be standards, regulations, and traceability. Such responsibility is deeply imprinted in the botanical medicine and herbal product industries; Good Manufacturing Practices (or any GxP) are the same across industry and jurisdictional boundaries. At the state-level there has been a proliferation of policies and laws that relax cannabidiol issues, while operators and producers are voluntarily adopting good practices.
This webinar, provided by Patient Focused Certification (PFC), will cover the need for regulatory inspection preparedness in the cannabis industry. And the most common violations that result in fines and potentially the denial or loss of an operating license. Learn about how PFC services help cannabis operations pass regulatory inspections, specifically for phase II licensing in states such as Maryland.
John A. MacKay earned a B.A. in Chemistry from St. Lawrence University, and Ph.D. from the University of Vermont in chemistry focused on the synthesis for cancer fighting compounds. After positions teaching at Davidson College, Lyndon State College and University of Vermont (UVM), John joined Waters Corporation in 1983. His career has included many roles in innovative product development and currently leads the Strategic Technology team. He is widely recognized as scientific expert in sub and supercritical fluid for extraction and chromatography in the botanical space.
This webinar is an introduction to the Patient Focused Certification program and was recorded live on May 3, 2017. It was hosted by Jahan Marcu, Ph.D., Americans for Safe Access Chief Science Officer and Patient Focused Certification Auditor.
Americans for Safe Access Foundation (ASA) and The Answer Page, Inc. have created the Cannabis Care Certification (CCC) program to help doctors provide the best care for legal medical cannabis patients, and to help patients get the most from their medical cannabis use. CCC has been created by recognized world experts and includes online educational tools for medical professionals, patients, and their caregivers to better understand the role of cannabis therapeutics through a structured learning environment. The CCC program has been designed for individuals as well as for companies and organizations that need to meet state requirements for patient medical cannabis education or CME requirements for physicians.